Refine
Year of publication
- 2017 (51) (remove)
Document Type
- Doctoral Thesis (51) (remove)
Is part of the Bibliography
- yes (51) (remove)
Keywords
- Antibiotika (1)
- Australia (1)
- Australien (1)
- Autotrophie (1)
- Bakterien Sensor (1)
- Bioinformatik (1)
- Biosynthese (1)
- Constraint-basierte Modellierung (1)
- Cre Rekombinase (1)
- Cre recombinase (1)
- Cyanobakterien (1)
- DNA (1)
- DNA assembly (1)
- DNS Assemblierung (1)
- Datenintegration (1)
- Diversität (1)
- Durchflusszytometrie (1)
- El`gygytgyn Kratersee (1)
- El’gygytgyn Crater Lake (1)
- European bats (1)
- Europäische Fledermausarten (1)
- Eutrophierung (1)
- Evolutionsgenetik (1)
- Fotoschalter (1)
- GTPase (1)
- Grundwasser (1)
- Haptene (1)
- Huftiere (1)
- Hybridom (1)
- Immunfluoreszenz (1)
- Klimawandel (1)
- Kohlenhydrat-Protein Interaction (1)
- Kohlenstoffisotope (1)
- LAMP (1)
- Landschaftsanalyse (1)
- Licht (1)
- Litoral (1)
- Makrophyten (1)
- Microviridin (1)
- Mikrobiologie (1)
- NGS (1)
- Naturschutz (1)
- Naturstoffe (1)
- Nettoproduktion (1)
- Optimierung von Biosynthesewegen (1)
- Optogenetik (1)
- Pathogen (1)
- Periphyton (1)
- Pharmakodynamik (1)
- Phylogeographie (1)
- Populationsökologie (1)
- Protease-Inhibitoren (1)
- Pyrophosphat (1)
- ROS (1)
- Radiokarbon (1)
- Reptilien (1)
- RiPP (1)
- Rubisco (1)
- Southeast Asia (1)
- Stoffwechselnetze (1)
- Systemsbiologie (1)
- Südostasien (1)
- Talsperre (1)
- Thermoregulationsverhalten (1)
- Tiefe Biosphäre (1)
- Transkriptionsfaktor (1)
- Vorhersagemodelle (1)
- Wirkstoffinteraktionen (1)
- Wüste (1)
- aldehyde (1)
- antibiotic combinations (1)
- asymmetric competition (1)
- asymmetrische Konkurrenz (1)
- autotrophy (1)
- bacterial population growth (1)
- bacterial sensor (1)
- benthic primary producers (1)
- benthische Primärproduzenten (1)
- bifunctional enzyme (1)
- biogeography (1)
- bioinformatics (1)
- biosynthesis (1)
- carbohydrate-protein interaction (1)
- carbon isotopes (1)
- chloro-ribosome (1)
- climate change (1)
- conservation (1)
- constraint-based modeling (1)
- conventional agriculture (1)
- cyanobacteria (1)
- data integration (1)
- deep biosphere (1)
- degradation (1)
- desert (1)
- diversity (1)
- drug drug interactions (1)
- evolutionary history (1)
- flow cytometry (1)
- freshwater ecosystems (1)
- fusion (1)
- galactolipids (1)
- gelöster organischer Kohlenstoff (1)
- giant unilamellar vesicles (1)
- groundwater (1)
- hapten (1)
- high resolution mass spectrometry (1)
- hochauflösende Massenspektrometrie (1)
- hybridoma (1)
- immunofluorescence (1)
- interspecific interactions (1)
- interspezifische Wechselwirkungen (1)
- isothermal amplification (1)
- isothermale Amplifikation (1)
- konventionelle Landwirtschaft (1)
- landscape analysis (1)
- light (1)
- littoral eutrophication (1)
- macrophytes (1)
- mathematical modelling (1)
- mathematische Modellierung (1)
- metabolic networks (1)
- microbial decomposition (1)
- microbiology (1)
- microviridin (1)
- mikrobieller Abbau (1)
- mitochondrial transformation (1)
- monoclonal antibodies (1)
- monoklonale Antikörper (1)
- morphological changes (1)
- morphologischen Veränderungen (1)
- natural products (1)
- net production (1)
- optogenetics (1)
- organic carbon (1)
- organic matter quality (1)
- organischer Kohlenstoff (1)
- organisches Material (1)
- oxidase (1)
- pathogen (1)
- pathway engineering (1)
- peptide (1)
- periphyton (1)
- pharmacodynamics (1)
- photoswitches (1)
- photosynthesis (1)
- plastid transformation (1)
- population ecology (1)
- predictive modelling (1)
- protease inhibitor (1)
- pyrophosphate (1)
- radiocarbon (1)
- reactive oxygen species (1)
- reptiles (1)
- ribosomal dynamics (1)
- ribosome assembly (1)
- riesen unilamellare Vesikel (1)
- sulfadiazine (1)
- synthetic biology (1)
- synthetische Biologie (1)
- systems biology (1)
- thermoregulatory behaviour (1)
- time-kill curves (1)
- tobacco (1)
- tobramycin (1)
- transcription factor (1)
- translation (1)
- ungulates (1)
- water reservoir (1)
Institute
- Institut für Biochemie und Biologie (51) (remove)
Natural products and their derivatives have always been a source of drug leads. In particular, bacterial compounds have played an important role in drug development, for example in the field of antibiotics. A decrease in the discovery of novel leads from natural sources and the hope of finding new leads through the generation of large libraries of drug-like compounds by combinatorial chemistry aimed at specific molecular targets drove the pharmaceutical companies away from research on natural products. However, recent technological advances in genetics, bioinformatics and analytical chemistry have revived the interest in natural products. The ribosomally synthesized and post-translationally modified peptides (RiPPs) are a group of natural products generated by the action of post-translationally modifying enzymes on precursor peptides translated from mRNA by ribosomes. The great substrate promiscuity exhibited by many of the enzymes from RiPP biosynthetic pathways have led to the generation of hundreds of novel synthetic and semisynthetic variants, including variants carrying non-canonical amino acids (ncAAs). The microviridins are a family of RiPPs characterized by their atypical tricyclic structure composed of lactone and lactam rings, and their activity as serine protease inhibitors. The generalities of their biosynthetic pathway have already been described, however, the lack of information on details such as the protease responsible for cleaving off the leader peptide from the cyclic core peptide has impeded the fast and cheap production of novel microviridin variants. In the present work, knowledge on leader peptide activation of enzymes from other RiPP families has been extrapolated to the microviridin family, making it possible to bypass the need of a leader peptide. This feature allowed for the exploitation of the microviridin biosynthetic machinery for the production of novel variants through the establishment of an efficient one-pot in vitro platform. The relevance of this chemoenzymatic approach has been exemplified by the synthesis of novel potent serine protease inhibitors from both rationally-designed peptide libraries and bioinformatically predicted microviridins. Additionally, new structure-activity relationships (SARs) could be inferred by screening microviridin intermediates. The significance of this technique was further demonstrated by the simple incorporation of ncAAs into the microviridin scaffold.